for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Mylan And Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval Of Hulio (Adalimumab-Fkjp)

July 9 (Reuters) - Mylan NV:

* MYLAN AND FUJIFILM KYOWA KIRIN BIOLOGICS ANNOUNCE U.S. FDA APPROVAL OF HULIO® (ADALIMUMAB-FKJP)

* MYLAN AND FUJIFILM KYOWA KIRIN BIOLOGICS ANNOUNCE U.S. FDA APPROVAL OF HULIO® (ADALIMUMAB-FKJP)

* MYLAN NV - MYLAN WILL BE ABLE TO LAUNCH HULIO IN U.S. DURING JULY 2023.

* MYLAN NV - WILL BE ABLE TO LAUNCH HULIO IN U.S. DURING JULY 2023 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up